Interferon-gamma release assays for tuberculosis: current and future applications

References

• Squire SB, Obasi A, Nhlema-Simwaka B. The Global Plan to Stop TB : a unique opportunity to address poverty and the Millennium Development Goals. Lancet 367(9514), 955–957 (2006).
   Google Scholar
• Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131(6), 1898–1906 (2007).
   PubMed Web of Science ®Google Scholar
• Evans CA. GeneXpert – a game-changer for tuberculosis control? PLoS Med. 8(7), e1001064 (2011).
   Google Scholar
• Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146(5), 340–354 (2007).
   PubMed Web of Science ®Google Scholar
• Samandari T, Agizew TB, Nyirenda S et al. 6-Month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 377(9777), 1588–1598 (2011).
   PubMed Web of Science ®Google Scholar
• Cain KP, Garman KN, Laserson KF et al. Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee. Am. J. Respir. Crit. Care Med. 186(3), 273–279 (2012).
   Google Scholar
• Mwinga A, Hosp M, Godfrey-Faussett P et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 12(18), 2447–2457 (1998).
   Web of Science ®Google Scholar
• Bergstedt W, Tingskov PN, Thierry-Carstensen B et al. First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent. PLoS ONE 5(6), e11277 (2010).
   Google Scholar
• Behr MA, Wilson MA, Gill WP et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284(5419), 1520–1523 (1999).
   PubMed Web of Science ®Google Scholar
• Mustafa AS, Cockle PJ, Shaban F, Hewinson RG, Vordermeier HM. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin. Exp. Immunol. 130(1), 37–42 (2002).
   Google Scholar
• Lalvani A, Pathan AA, McShane H et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am. J. Respir. Crit. Care Med. 163(4), 824–828 (2001).
   Google Scholar
• van Ingen J, de Zwaan R, Dekhuijzen R. Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J. Bacteriol. 191(18), 5865–5867 (2009).
   PubMed Web of Science ®Google Scholar
• Holland SM. Nontuberculous mycobacteria. Am. J. Med. Sci. 321(1), 49–55 (2001).
   PubMed Web of Science ®Google Scholar
• Pai M, Zwerling A, Menzies D. T-Cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149(3), 177–184 (2008).
   PubMed Web of Science ®Google Scholar
• Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB. Chest 137(4), 952–968 (2010).
   PubMed Web of Science ®Google Scholar
• Sester M, Sotgiu G, Lange C et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 37(1), 100–111 (2011).
   PubMed Web of Science ®Google Scholar
• Cattamanchi A, Smith R, Steingart KR et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J. Acquir. Immune Defic. Syndr. 56(3), 230–238 (2011).
   PubMed Web of Science ®Google Scholar
• Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann. Intern. Med. 146(5), 340–354 (2007).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Pareek M. A 100-year update on diagnosis of tuberculosis infection. Br. Med. Bull. 93, 69–84 (2009).
   Google Scholar
• Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement. In: World Health Organisation, WHO Press, Geneva, CH, Switzerland (2011).
   Google Scholar
• Chapman AL, Munkanta M, Wilkinson KA et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16(17), 2285–2293 (2002).
   Google Scholar
• Liebeschuetz S, Bamber S, Ewer K et al. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364(9452), 2196–2203 (2004).
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Diwakar L, Seldon R et al. Clinical, immunological, and epidemiological importance of antituberculosis T Cell responses in HIV-infected africans. Clin. Infect. Dis. 44(12), 1639–1646 (2007).
   Google Scholar
• Goletti D, Carrara S, Vincenti D, Girardi E. T Cell responses to commercial Mycobacterium tuberculosis specific antigens in HIV-infected patients. Clin. Infect. Dis. 45(12), 1652–1654 (2007).
   Google Scholar
• Vincenti D, Carrara S, Butera O et al. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin. Exp. Immunol. 150(1), 91–98 (2007).
   Google Scholar
• Clark SA, Martin SL, Pozniak A et al. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin. Exp. Immunol. 150(2), 238–244 (2007).
   Google Scholar
• Raby E, Moyo M, Devendra A et al. The effects of HIV on the sensitivity of a whole blood IFN-γ release assay in Zambian adults with active tuberculosis. PLoS ONE 3(6), e2489 (2008).
   Google Scholar
• Aabye MG, Ravn P, Pray God G et al. The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS ONE 4(1), e4220 (2009).
   Google Scholar
• Santin M, Munoz L, Rigau D. Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS ONE 7(3), e32482 (2012).
   PubMed Web of Science ®Google Scholar
• Oni T, Gideon HP, Bangani N et al. Risk factors associated with indeterminate gamma interferon responses in the assessment of latent tuberculosis infection in a high-incidence environment. Clinical and vaccine immunology. Clin. Vaccine Immonol. 19(8), 1243–1247 (2012).
   Google Scholar
• British HIV Association (BHIVA). British HIV association guidelines for the treatment of TB/HIV coinfection. HIV Med. 12(9), 517–524 (2011).
   Google Scholar
• National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians (2011).
   Google Scholar
• European Centre for Disease Prevention and Control. In: Use of interferon-gamma release assays in support of TB diagnosis. European Centre for Disease Prevention and Control, Stockholm, SE, Sweden (2011).
   Google Scholar
• American Thoracic Society (ATS). Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161(4 Pt 2), S221–S247 (2000).
   Google Scholar
• World Health Organisation. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. In: World Health Organisation WHO Press, Geneva, CH, Switzerland (2011).
   Google Scholar
• Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin. Microbiol. Infect. 17(6), 806–814 (2011).
   PubMed Web of Science ®Google Scholar
• Smith R, Cattamanchi A, Steingart KR et al. Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr. Opin. Rheumatol. 23(4), 377–384 (2011).
   PubMed Web of Science ®Google Scholar
• Martyn-Simmons CL, Mee JB, Kirkham BW, Groves RW, Milburn HJ. Evaluating the use of the interferon-gamma response to Mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-alpha therapy: a prospective head-to-head cross-sectional study. Br. J. Dermatol. 168(5), 1012–1018 (2013).
   Google Scholar
• Vassilopoulos D, Tsikrika S, Hatzara C et al. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy. Clin. Vaccine Immunol. 18(12), 2102–2108 (2011).
   PubMed Web of Science ®Google Scholar
• Cush JJ, Winthrop KW, Dao K, Chaisson RE. Screening for Mycobacterium tuberculosis infection: questions and answers for clinical practice. Drug Safety Quart. 1, 1 (2010).
   Google Scholar
• Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 15(8), 1018–1032 (2011).
   PubMed Web of Science ®Google Scholar
• Yassin MA, Petrucci R, Garie KT et al. Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection. Eur. Respir. J. 41(3), 644–648 (2013).
   Google Scholar
• Public Health Agency of Canada. Interferon gamma release assays for latent tuberculosis infection: an advisory committee statement Can. Commun. Dis. Rep. 33(ACS–10), 1–18 (2007).
   Google Scholar
• Mazurek GH, Jereb J, Lobue P. et al. . MMWR Recomm. Rep. 54(RR–15), 49–55 (2005).
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection. MMWR Recomm. Rep. 59(RR–5), 1–25 (2010).
   Google Scholar
• Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 131(5), 1424–1434 (2007).
   Google Scholar
• Wrighton-Smith P, Zellweger JP. Direct costs of three models for the screening of latent tuberculosis infection. Eur. Respir. J. 28(1), 45–50 (2006).
   Google Scholar
• Health Protection Agency. Tuberculosis in the UK: annual report on tuberculosis surveillance and control in the UK 2011. In: Health Protection Agency Centre for Infections. London, UK (2011).
   Google Scholar
• Arshad S, Bavan L, Gajari K, Paget SNJ, Baussano I. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur. Respir. J. 35(6), 6–1345 (2010).
   Google Scholar
• Erkens C, Slump E, Kamphorst M et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur. Respir. J. 32(1), 153–161 (2008).
   Google Scholar
• Pareek M, Watson JP, Ormerod LP et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Infect. Dis. 11(6), 435–444 (2011).
   Web of Science ®Google Scholar
• Pareek M, Bond M, Shorey J et al. Community-based evaluation of immigrant tuberculosis screening using interferon-γ release assays and tuberculin skin testing: observational study and economic analysis. Thorax doi: 10.1136/thoraxjnl-2011-201542 (2012) ( Epub ahead of print).
   Google Scholar
• Lalvani A, Pathan AA, Durkan H et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357(9273), 2017–2021 (2001).
   PubMed Web of Science ®Google Scholar
• Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole-blood IFN-gamma assay for the development of active TB disease. Am. J. Respir. Crit. Care Med. 177(10), 1164–1170 (2008).
   Web of Science ®Google Scholar
• Bakir M, Millington KA, Soysal A et al. Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact. Ann. Intern. Med. 149(11), 777–786 (2008).
   Google Scholar
• Diel R, Goletti D, Ferrara G et al. Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur. Respir. J. 37(1), 88–99 (2011).
   Google Scholar
• Rangaka MX, Wilkinson KA, Glynn JR et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect. Dis. 12(1), 45–55 (2012).
   PubMed Web of Science ®Google Scholar
• Nardell EA, Wallis RS. Here today-gone tomorrow: the case for transient acute tuberculosis infection. Am. J. Respir. Crit. Care Med. 174(7), 734–735 (2006).
   Google Scholar
• Ewer K, Millington KA, Deeks JJ et al. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 174(7), 831–839 (2006).
   PubMed Web of Science ®Google Scholar
• Millington KA, Gooding S, Hinks TS, Reynolds DJ, Lalvani A. Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosis. J. Infect. Dis. 202(11), 1685–1689 (2010).
   Google Scholar
• Richeldi L, Ewer K, Losi M, Bergamini BM et al. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 119(1), e1–e5 (2007).
   Google Scholar
• Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367(3517), 1173–1180 (2006).
   Google Scholar
• Colditz GA, Brewer TF, Berkey CS et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271(9), 698–702 (1994).
   PubMed Web of Science ®Google Scholar
• Clemens JD, Chuong JJ, Feinstein AR. The BCG controversy. A methodological and statistical reappraisal. JAMA 249(17), 2362–2369 (1983).
   PubMed Web of Science ®Google Scholar
• Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 177(10), 1164–1170 (2008).
   Web of Science ®Google Scholar
• Soysal A, Millington KA, Bakir M et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 366(9495), 1443–1451 (2005).
   Google Scholar
• Eisenhut M, Paranjothy S, Abubakar I et al. BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine 27(44), 6116–6120 (2009).
   Web of Science ®Google Scholar
• Eriksen J, Chow JY, Mellis V et al. Protective effect of BCG vaccination in a nursery outbreak in 2009: time to reconsider the vaccination threshold? Thorax 65(12), 1067–1071 (2010).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Sridhar S. BCG vaccination: 90 years on and still so much to learn. Thorax 65(12), 1036–1038 (2010).
   PubMed Web of Science ®Google Scholar
• Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 137(4), 952–968 (2010).
   PubMed Web of Science ®Google Scholar
• Metcalfe JZ, Everett CK, Steingart KR et al. Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J. Infect. Dis. 204( Suppl. 204), S1120–S1129 (2011).
   PubMed Web of Science ®Google Scholar
• Borgdorff M, Behr M, Nagelkerke N, Hopewell P, Small P. Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int. J. Tuberc. Lung Dis. 4(4), 287–294 (2000).
   Google Scholar
• Dosanjh DP, Hinks TS, Innes JA et al. Improved diagnostic evaluation of suspected tuberculosis. Ann. Intern. Med. 148(5), 325–336 (2008).
   Google Scholar
• Jafari C, Thijsen S, Sotgiu G et al. Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis. Am. J. Respir. Crit. Care Med. 180(7), 666–673 (2009).
   Google Scholar
• Jafari C, Kessler P, Sotgiu G, Ernst M, Lange C. Impact of a Mycobacterium tuberculosis-specific interferon-γ release assay in bronchoalveolar lavage fluid for a rapid diagnosis of tuberculosis. J. Int. Med. 270(3), 254–262 (2011).
   Google Scholar
• Dheda K, van Zyl-Smit RN, Meldau R et al. Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis. Thorax 64(10), 847–853 (2009).
   Google Scholar
• Cattamanchi A, Ssewenyana I, Nabatanzi R et al. Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients. PLoS ONE 7(6), e39838 (2012).
   PubMed Web of Science ®Google Scholar
• Wilkinson KA, Wilkinson RJ, Pathan A et al. Ex vivo characterization of early secretory antigenic target 6-specific T cells at sites of active disease in pleural tuberculosis. Clin. Infect. Dis. 40(1), 184–187 (2005).
   Google Scholar
• Jafari C, Ernst M, Strassburg A et al. Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot. Eur. Respir. J. 31(2), 261–265 (2008).
   Google Scholar
• Thomas MM, Hinks TS, Raghuraman S et al. Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. Int. J. Tuberc. Lung Dis. 12(6), 651–657 (2008).
   Google Scholar
• Kim SH, Cho OH, Park SJ et al. Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin.l Infect. Dis. 50(10), 1349–1358 (2010).
   PubMed Web of Science ®Google Scholar
• Murakami S, Takeno M, Oka H et al. Diagnosis of tuberculous meningitis due to detection of ESAT-6-specific gamma interferon production in cerebrospinal fluid enzyme-linked immunospot assay. Clin. Vaccine Immunol. 15(5), 897–899 (2008).
   Google Scholar
• Lalvani A, Millington KA. T-cell interferon-gamma release assays: can we do better? Eur. Respir. J. 32(6), 1428–1430 (2008).
   Google Scholar
• Sridhar S, Pollock K, Lalvani A. Redefining latent tuberculosis. Future Microbiol. 6(9), 1021–1035 (2011).
   PubMed Web of Science ®Google Scholar
• Whitworth HS, Scott M, Connell DW, Donges B, Lalvani A. IGRAs – the gateway to T cell based TB diagnosis. Methods 61(1), 52–62 (2013).
   Google Scholar
• Abubakar I, Stagg HR, Whitworth H, Lalvani A. How should I interpret an interferon gamma release assay result for tuberculosis infection? Thorax 68(3), 298–301 (2013).
   Google Scholar
• Harada N, Higuchi K, Yoshiyama T et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J. Infect. 56(5), 348–353 (2008).
   Google Scholar
• Mahomed H, Hughes EJ, Hawkridge T et al. Comparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int. J. Tuberc. Lung Dis. 10(3), 310–316 (2006).
   Google Scholar
• Dosanjh DPS, Bakir M, Millington KA et al. Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression. PLoS ONE 6(12), e28754 (2011).
   Google Scholar
• Millington KA, Fortune SM, Low J, Garces A et al. Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. 108(14), 5730–5735 (2011).
   PubMed Web of Science ®Google Scholar
• Lalvani A, Millington KA. T-cell interferon-gamma release assays: can we do better? Eur. Respir. J. 32(6), 1428–1430 (2008).
   Google Scholar
• Ruhwald M, Bodmer T, Maier C et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur. Respir. J. 32(6), 1607–1615 (2008).
   PubMed Web of Science ®Google Scholar
• Wang S, Diao N, Lu C et al. Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS ONE 7(12), e58 (2012).
   Google Scholar
• Yassin MA, Petrucci R, Garie KT et al. Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection. Eur. Respir. J. 41(3), 644–648 (2013).
   Google Scholar
• Vanini V, Petruccioli E, Gioia C et al. IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J. Infect. 65(1), 49–59 (2012).
   Google Scholar
• Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev. Mol. Diagn. 12(2), 175–187 (2012).
   PubMed Web of Science ®Google Scholar
• Tufariello JM, Jacobs WR Jr, Chan J. Infect. Immun. 72(1), 515–526 (2004).
   Google Scholar
• Wayne LG . Methods Mol. Med. 54, 247–269 (2001).
   PubMedGoogle Scholar
• Leyten EM, Lin MY, Franken KL et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect. 8(8), 2052–2060 (2006).
   PubMed Web of Science ®Google Scholar
• Goletti D, Butera O, Vanini V et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur. Respir. J. 36(1), 135–142 (2010).
   PubMed Web of Science ®Google Scholar
• Chiacchio T, Petruccioli E, Vanini V et al. Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS ONE 6(11), e27539 (2011).
   Google Scholar
• Casey R, Blumenkrantz D, Millington KA et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS ONE 5(12), e15619 (2010).
   Google Scholar
• Harari A, Rozot V, Enders FB et al. Dominant TNF-alpha(+) Mycobacterium tuberculosis-specific CD4(+) T cell responses discriminate between latent infection and active disease. Nat. Med. 17(3), 372–376 (2011).
   PubMed Web of Science ®Google Scholar
• Sester U, Fousse M, Dirks J et al. Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active States. PLoS ONE 6(3), e17813 (2011).
   PubMed Web of Science ®Google Scholar
• Pantaleo G, Harari A. Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 6(5), 417–423 (2006).
   Google Scholar
• Millington KA, Gooding S, Hinks TS, Reynolds DJ, Lalvani A. Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated self-healed tuberculosis. J. Infect. Dis. 202(11), 1685–1689 (2010).
   Google Scholar
• Day CL, Abrahams DA, Lerumo L et al. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 187(5), 2222–2232 (2011).
   PubMed Web of Science ®Google Scholar
• Corbiere V, Pottier G, Bonkain F et al. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. PLoS ONE 7(8), e43285 (2012).
   Google Scholar
• Mistry R, Cliff JM, Clayton CL et al. Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J. Infect. Dis. 195(3), 357–365 (2007).
   Google Scholar
• Agranoff D, Fernandez-Reyes D, Papadopoulos MC et al. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368(9540), 1012–1021 (2006).
   PubMed Web of Science ®Google Scholar